Search

Displaying results 5021 - 5030 of 10000 in total
  1. Drug

    Aloe vera flower

    go.drugbank.com/drugs/DB14254
    Approved

    Aloe vera flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  2. Drug

    Corydalis ambigua tuber

    go.drugbank.com/drugs/DB14279
    Approved

    Corydalis ambigua tuber is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  3. Drug

    Lonicera caprifolium flower

    go.drugbank.com/drugs/DB14280
    Approved

    Lonicera caprifolium flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  4. Drug

    Larix sibirica wood

    go.drugbank.com/drugs/DB14289
    ApprovedWithdrawn

    Larix sibirica wood is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  5. Drug

    Apricot kernel oil

    go.drugbank.com/drugs/DB14324
    Approved

    Apricot kernel oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  6. Drug

    Azadirachta indica leaf

    go.drugbank.com/drugs/DB14352
    Approved

    Azadirachta indica leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  7. Drug

    ATX-101

    go.drugbank.com/drugs/DB05780
    Investigational

    Deoxycholic acid is a naturally occurring bile acid produced by the liver as one of several end products of cholesterol metabolism. … As a naturally occurring component of the human body, deoxycholate is considered a ‘biocompatible’ detergent that solubilizes fat in the small intestine.

  8. Drug

    MPT0B640

    go.drugbank.com/drugs/DB16512
    Investigational

    MPT0B640 was under investigation in clinical trials NCT04526717 for COVID-19 infection and NCT04294875 for locally advanced or metastatic solid malignancies.

  9. Drug

    V591

    go.drugbank.com/drugs/DB16438
    Investigational

    The V591 vaccine, part of Merck’s COVID-19 vaccine programming, was developed using a modified measles vaccine virus as a vector for COVID-19 antigen delivery[L30593]. … Through Merck’s acquisition of Thermis in May 2020, they were able to leverage Thermis’ platform knowledge and accelerate the development of V591 to phase I clinical trials (NCT04498247)[L30593].

  10. Drug

    Marimastat

    go.drugbank.com/drugs/DB00786
    Investigational

    Used in the treatment of cancer, Marmiastat is an angiogenesis and metastasis inhibitor. As an angiogenesis inhibitor it limits the growth and production of blood vessels. … As an antimetatstatic agent it prevents malignant cells from breaching the basement membranes.